Summarized by Masters of Longevity from Longevity Technology.
Cell-therapy manufacturing partnership: a report you can open to learn how a CDMO deal aims to scale licensed perinatal MuseCell production and infrastructure.
Key Takeaways
- Celularity will manufacture Dezawa MuseCells and two related products under license from MuseCell Innovations.
- The deal could bring up to $300 million of business and create more than 200 jobs in New Jersey.
- Production will occur at Celularity's 147,215 sq ft Florham Park facility using existing cleanroom suites.
